Mark Watson
Impact in
- Microbiology top 5%
- Reproductive tract infections research
- Immunology top 10%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
- Immunology 15
- Immune Cell Function and Interaction 9
- Immunotherapy and Immune Responses 5
- Oncology 13
- Cancer Immunotherapy and Biomarkers 8
- Co-authors
- Ian N. Clarke (6 shared papers)Paul R. Lambden (5 shared papers)Manfred W. Beilharz (4 shared papers)James Flexman (10 shared papers)C M Lawson (2 shared papers)Abha Chopra (15 shared papers)Patricia Price (6 shared papers)Silvia Lee (7 shared papers)
- Journals
- Journal of Clinical Microbiology (2 papers)Microbiology (2 papers)Nucleic Acids Research (2 papers)Frontiers in Immunology (2 papers)Cellular Immunology (2 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Mark Watson
47 papers receiving 837 citations
Peers
Comparison fields: 5 of 96
- Microbiology 150
- Immunology 282
- Hepatology 62
- Virology 35
- Oncology 173
Countries citing papers authored by Mark Watson
This map shows the geographic impact of Mark Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Watson more than expected).
Fields of papers citing papers by Mark Watson
This network shows the impact of papers produced by Mark Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Watson. The network helps show where Mark Watson may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Watson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 72 | |
| 2 | 2004 | 60 | |
| 3 | 2020 | 59 | |
| 4 | 1991 | 52 | |
| 5 | 2020 | 48 | |
| 6 | 1997 | 42 | |
| 7 | 2020 | 39 | |
| 8 | 1994 | 36 | |
| 9 | 1999 | 33 | |
| 10 | 2010 | 33 | |
| 11 | 1999 | 30 | |
| 12 | 1996 | 27 | |
| 13 | 2015 | 27 | |
| 14 | 2017 | 26 | |
| 15 | 2004 | 25 | |
| 16 | 1989 | 21 | |
| 17 | 2010 | 17 | |
| 18 | 1990 | 17 | |
| 19 | 2017 | 16 | |
| 20 | 2019 | 15 |
About Mark Watson
Mark Watson is a scholar working on Immunology, Oncology, Epidemiology, Hepatology and Infectious Diseases, having authored 51 papers that have together received 870 indexed citations. Recurring topics across this work include Hepatitis C virus research (10 papers), Immune Cell Function and Interaction (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), Clostridium difficile and Clostridium perfringens research (5 papers), Immunotherapy and Immune Responses (5 papers), HIV Research and Treatment (5 papers), Reproductive tract infections research (5 papers) and Parasitic Infections and Diagnostics (3 papers). The work is most often cited by research in Microbiology (150 citations), Immunology (282 citations), Hepatology (62 citations), Virology (35 citations) and Oncology (173 citations). Mark Watson has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Ian N. Clarke, Paul R. Lambden, Manfred W. Beilharz, James Flexman, C M Lawson, Abha Chopra, Patricia Price, Silvia Lee, Anna K. Nowak and W. Joost Lesterhuis. Their work appears in journals such as Journal of Clinical Microbiology, Microbiology, Nucleic Acids Research, Frontiers in Immunology and Cellular Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.